Medical research

Ivermectin does not prevent progression to severe COVID-19

Ivermectin treatment during early illness does not prevent progression to severe disease for high-risk patients with mild-to-moderate COVID-19, according to a study published online Feb. 18 in JAMA Internal Medicine.

Diseases, Conditions, Syndromes

Unvaccinated have highest SARS-CoV-2 incidence, hospitalization

(HealthDay)—Severe acute respiratory syndrome coronavirus 2 incidence and hospitalization rates are consistently higher for unvaccinated persons, and rates are lowest for those fully vaccinated with a booster, according ...

Diseases, Conditions, Syndromes

Patients hospitalized with COVID-19 less likely to be vaccinated

Patients with COVID-19 hospitalization and disease progression to death or mechanical ventilation are significantly less likely to be vaccinated with an mRNA COVID-19 vaccine, according to a study published online Nov. 4 ...

page 12 from 37